<DOC>
	<DOCNO>NCT00005586</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining one drug may kill tumor cell . It yet know whether chemotherapy effective observation patient surgery remove colorectal cancer . PURPOSE : This randomized phase III trial study leucovorin fluorouracil see well work compare observation treat patient colorectal cancer surgically remove .</brief_summary>
	<brief_title>Leucovorin Fluorouracil Compared With Observation Treating Patients With Colorectal Cancer That Has Been Surgically Removed</brief_title>
	<detailed_description>OBJECTIVES : - Compare all-cause mortality patient resect colorectal cancer treat adjuvant chemotherapy L-leucovorin fluorouracil v observation . - Compare recurrence rate patient treated regimen vs observation . - Compare effectiveness monthly 5-day schedule vs weekly schedule L-leucovorin fluorouracil patient population . OUTLINE : This randomize , open-label , multicenter study . Patients randomize receive adjuvant chemotherapy ( arm I ) undergo observation ( arm II ) . - Arm I : Within 12 week surgery , patient receive L-leucovorin IV follow fluorouracil IV day 1-5 every 4 week 6 course . Alternatively , patient may receive L-leucovorin IV follow fluorouracil IV day 1 weekly 30 week . - Arm II : Patients undergo observation . Patients follow annually . PROJECTED ACCRUAL : A total 2,500 patient ( 1,250 per arm ) accrue study .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<mesh_term>Levoleucovorin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Completely resect stage II III colorectal cancer No distant metastases No positive resection margin No positive peritoneal washing PATIENT CHARACTERISTICS : Age : 18 Performance status : Not specify Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify Other : No clear definite indication , contraindication , systemic chemotherapy Lleucovorin fluorouracil PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No concurrent chemotherapy observation arm Endocrine therapy : Not specify Radiotherapy : Concurrent radiotherapy allow adjuvant chemotherapy arm provide chemotherapy administered weekly schedule Surgery : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2007</verification_date>
	<keyword>stage II colon cancer</keyword>
	<keyword>stage III colon cancer</keyword>
	<keyword>stage II rectal cancer</keyword>
	<keyword>stage III rectal cancer</keyword>
</DOC>